AGL Stock Overview
Provides healthcare services for seniors through primary care physicians in the communities of the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
agilon health, inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.90 |
| 52 Week High | US$13.28 |
| 52 Week Low | US$1.50 |
| Beta | 0.52 |
| 1 Month Change | -9.09% |
| 3 Month Change | -48.23% |
| 1 Year Change | -84.86% |
| 3 Year Change | -93.15% |
| 5 Year Change | n/a |
| Change since IPO | -93.87% |
Recent News & Updates
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 10
agilon health Plunges On A Poor Prognosis (Rating Downgrade)
Nov 08Recent updates
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 10agilon health Plunges On A Poor Prognosis (Rating Downgrade)
Nov 08Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Oct 15agilon health: Interesting Business Model, But Volatile And Uncertain
Aug 16Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower
Aug 16Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Jul 15The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More
Jun 06agilon health: Still Not Healthy Enough To Warrant Upside
Apr 19Is agilon health (NYSE:AGL) Using Too Much Debt?
Apr 04agilon health: High Growth But Unsustainable Economics
Nov 20agilon health: Strong Sales Growth, Lacks Remaining Value Drivers
Sep 13Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues
Jul 17agilon health: A Hold Until Margins Are Improved
Jun 30An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued
Jun 06Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?
Apr 28Shareholder Returns
| AGL | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 2.7% | 1.3% | 0.6% |
| 1Y | -84.9% | -9.7% | 23.7% |
Return vs Industry: AGL underperformed the US Healthcare industry which returned -9.7% over the past year.
Return vs Market: AGL underperformed the US Market which returned 23.7% over the past year.
Price Volatility
| AGL volatility | |
|---|---|
| AGL Average Weekly Movement | 17.1% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AGL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: AGL's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 1,117 | Steve Sell | www.agilonhealth.com |
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021.
agilon health, inc. Fundamentals Summary
| AGL fundamental statistics | |
|---|---|
| Market cap | US$782.83m |
| Earnings (TTM) | -US$310.98m |
| Revenue (TTM) | US$5.59b |
0.1x
P/S Ratio-2.5x
P/E RatioIs AGL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AGL income statement (TTM) | |
|---|---|
| Revenue | US$5.59b |
| Cost of Revenue | US$5.65b |
| Gross Profit | -US$51.77m |
| Other Expenses | US$259.21m |
| Earnings | -US$310.98m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.75 |
| Gross Margin | -0.93% |
| Net Profit Margin | -5.56% |
| Debt/Equity Ratio | 6.1% |
How did AGL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 15:05 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
agilon health, inc. is covered by 29 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hua Ha | Baird |
| Andrew Mok | Barclays |
| William Sutherland | Benchmark Company |